Compare Harley-Davidson Inc (HOG) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harley-Davidson Inc vs Johnson & Johnson — how do they compare? Harley-Davidson Inc trades at $27.17 (market cap $2.78B), while Johnson & Johnson trades at $260.7 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 225.2× Harley-Davidson Inc's market cap, and Harley-Davidson Inc pays the higher dividend (2.75%). Which is the better fit depends on your goals.
| HOG | JNJ | |
|---|---|---|
Market Cap | $2.78B | $626.09B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.03 | $267.24 |
52-Week Low | $17.19 | $172.78 |
Enterprise Value | $3.19B | $654.37B |
Dividend Yield | 2.75% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Harley-Davidson (HOG) trades at $25.98, down 0.46% on the day, with a bullish technical signal from moving averages but mixed oscillators. Recent Q2 2026 earnings beat estimates at $0.75 per share versus $0.645 expected, though revenue declined year-over-year. The company raised full-year guidance, citing strong North American retail sales and cost-cutting initiatives under its 'Back to the Bricks' strategy, while returning Revolution Max engine production to the U.S.
The stock presents a value opportunity with a low P/E of 14.84 and P/S of 0.72, but faces headwinds from declining revenue and net margins. Analyst consensus is mixed with a $26 price target near the current price, indicating limited near-term upside. Key risks include competitive pressures, raw material cost inflation, and execution of the turnaround plan amid weakening profitability trends.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
